6086 logo

Fangzhou Inc. Stock Price

SEHK:6086 Community·HK$3.3b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

6086 Share Price Performance

HK$0
-6.93 (-100.00%)
HK$0
-6.93 (-100.00%)
Price HK$0

6086 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with moderate growth potential.

2 Risks
1 Reward

Fangzhou Inc. Key Details

CN¥2.9b

Revenue

CN¥2.4b

Cost of Revenue

CN¥518.7m

Gross Profit

CN¥542.4m

Other Expenses

-CN¥23.7m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.018
18.02%
-0.82%
0.007%
View Full Analysis

About 6086

Founded
2015
Employees
485
CEO
n/a
WebsiteView website
Jianke.com

Fangzhou Inc. provides online chronic disease management services in China. It operates through four segments: Online Retail Pharmacy Services; Comprehensive Medical Services; Wholesale; and Customized Content And Marketing Solutions. The company offers services through online chronic disease management platform to address the needs of patients with chronic disease, such as hypertension, cardiovascular and respiratory chronic diseases. It also provides H2H services, including online medical consultation services, e-prescription, and prescription refill services through mobile application; and healthcare products through online retail pharmacy service platform; as well as operates hospitals. Fangzhou Inc. was founded in 2015 and is based in Guangzhou, China.

Recent 6086 News & Updates

Recent updates

No updates